Head & Neck Cancer

Your multidisciplinary team of head and neck cancer specialists provides seamless care in as few visits as possible, as well as customized treatment based on the location of the tumor and how advanced it is. The team may include otolaryngologists, head and neck surgeons, reconstructive surgeons, plastic surgeons, oral-maxillofacial surgeons, endocrine surgeons, radiation and medical oncologists, and speech and swallowing therapists.

We offer advanced diagnostic tools, including PET/MRI, and targeted treatments such as immunotherapy and brachytherapy to deliver radiation therapy directly to the tumor. Our surgeons are pioneers in reconstructive surgical techniques, which may be an important part of your care.

Throughout treatment and recovery, we provide compassionate care and support services, such as speech and swallowing therapy.

Clinical Trials and Research Studies

Phase 6

RANDOMIZED PHASE II/III TRIAL OF SENTINEL LYMPH NODE BIOPSY VERSUS ELECTIVE NECK DISSECTION FOR EARLY-STAGE ORAL CAVITY CANCER

Learn More

Phase 1

Phase 1 Open-Label Multicenter Dose Escalation Study of mRNA-2752 a Lipid Nanoparticle Encapsulating mRNAs Encoding Human OX40L IL-23 and IL-36? for Intratumoral Injection Alone and in Combination with Immune Checkpoint Blockade

Learn More

Phase 5

A Phase 1/2a Multi-Center Open-Label Study to Evaluate the Safety Tolerability Pharmacokinetics and Preliminary Evidence of Antitumor Activity of JAB-3312 in combination with pembrolizumab or binimetinib in Adult Patients with Advanced Solid Tumors

Learn More

Phase 1

An Open Label First in Human (FIH) Phase 1 Trial of LVGN6051 as Single Agent and in Combination with Keytruda (pembrolizumab) in Advanced or Metastatic Malignancy

Learn More